Literature DB >> 26926530

The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.

Mary Rinella1, Michael Charlton2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26926530     DOI: 10.1002/hep.28524

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  64 in total

1.  Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.

Authors:  Mohammad Nasser Kabbany; Praveen Kumar Conjeevaram Selvakumar; Kymberly Watt; Rocio Lopez; Zade Akras; Nizar Zein; William Carey; Naim Alkhouri
Journal:  Am J Gastroenterol       Date:  2017-02-14       Impact factor: 10.864

2.  Liver fibrosis scores predict liver disease mortality in the United States population.

Authors:  Aynur Unalp-Arida; Constance E Ruhl
Journal:  Hepatology       Date:  2017-05-16       Impact factor: 17.425

3.  Non-alcoholic fatty liver disease and colorectal cancer survival.

Authors:  Kana Wu; Mike Z Zhai; Erin K Weltzien; Elizabeth M Cespedes Feliciano; Jeffrey A Meyerhardt; Edward Giovannucci; Bette J Caan
Journal:  Cancer Causes Control       Date:  2018-11-15       Impact factor: 2.506

4.  Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Zobair M Younossi; Rohit Loomba; Mary E Rinella; Elisabetta Bugianesi; Giulio Marchesini; Brent A Neuschwander-Tetri; Lawrence Serfaty; Francesco Negro; Stephen H Caldwell; Vlad Ratziu; Kathleen E Corey; Scott L Friedman; Manal F Abdelmalek; Stephen A Harrison; Arun J Sanyal; Joel E Lavine; Philippe Mathurin; Michael R Charlton; Naga P Chalasani; Quentin M Anstee; Kris V Kowdley; Jacob George; Zachary D Goodman; Keith Lindor
Journal:  Hepatology       Date:  2018-07       Impact factor: 17.425

5.  Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.

Authors:  Monika Sarkar; Melissa Wellons; Marcelle I Cedars; Lisa VanWagner; Erica P Gunderson; Veeral Ajmera; Laura Torchen; David Siscovick; J Jeffrey Carr; James G Terry; Mary Rinella; Cora E Lewis; Norah Terrault
Journal:  Am J Gastroenterol       Date:  2017-03-14       Impact factor: 10.864

6.  Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats.

Authors:  Yinji Liang; Shu Liang; Yupei Zhang; Yuanjun Deng; Yifang He; Yanning Chen; Chan Liu; Chenli Lin; Qinhe Yang
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

7.  Effects of knee loading on obesity-related non-alcoholic fatty liver disease in an ovariectomized mouse model with high-fat diet.

Authors:  Nian Tan; Xinle Li; Lidong Zhai; Daquan Liu; Jie Li; Hiroki Yokota; Ping Zhang
Journal:  Hepatol Res       Date:  2018-05-06       Impact factor: 4.288

Review 8.  Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.

Authors:  Min Seok Cho; Sang Yeol Kim; Ki Tae Suk; Byung-Yong Kim
Journal:  J Microbiol       Date:  2018-10-25       Impact factor: 3.422

Review 9.  Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease.

Authors:  Peter R Baker; Jacob E Friedman
Journal:  J Clin Invest       Date:  2018-08-31       Impact factor: 14.808

10.  Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis.

Authors:  Kyoko Tomita; Rohit Kohli; Brittany L MacLaurin; Petra Hirsova; Qianqian Guo; Luz H Gutierrez Sanchez; Harris A Gelbard; Burns C Blaxall; Samar H Ibrahim
Journal:  JCI Insight       Date:  2017-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.